Sign in
Create a Profile
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
Diseases and Conditions Researched
Type 1 Diabetes
What is the purpose of this trial?
Insulin treatment often causes the blood glucose levels to fall too low. The body usually responds to low blood glucose levels by releasing hormones which act against the insulin to help correct the low blood glucose levels. However, this hormone response can be altered in people with diabetes. Currently there are no therapeutic agents that can be used to improve the recovery from hypoglycemia (low blood sugar). The aim of this study is to determine whether a formoterol inhaler can be used to improve and accelerate the recovery from hypoglycemia in patients with type 1 diabetes.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsors: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Yale University |
|---|---|
| Dates: | September 1, 2010 |
| Last Updated: | July 11, 2011 |
| Study HIC#: | 1005006832 |
| Clinicaltrials.gov ID: | NCT01194479 |
How will my information be used?
For more information about this trial, contact:
Renata Belfort de Aguiar, MD
203-785-6222
glucose.studies@yale.edu
Sarita Naik, MD
203-785-6222
glucose.studies@yale.edu
Principal Investigator
Robert Sherwin, MD
Internal Medicine
Renata Belfort de Aguiar, MD
Sarita Naik, MD
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
